Value of sentinel lymph node procedure in endometrial cancer;La recherche du ganglion sentinelle dans le cancer de l'endomètre a-t-elle un intérêt ?

Gynecologie Obstetrique et Fertilite

Volumn 35, Issue 7-8, 2007, Pages 618-624

  Delpech, Y ^a   Coutant, C ^a   Morel, O ^b   Uzan, S ^a   Darai E ^a   Barranger, E ^b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Combined detection; Endometrial cancer; Laparoscopy; Micrometastasis; Prognosis; Sentinel lymph node

Indexed keywords

ARTICLE; BIOPSY; BREAST CANCER; ENDOMETRIUM CANCER; HUMAN; LYMPHADENECTOMY; MORBIDITY; PROGNOSIS; SENTINEL LYMPH NODE; ENDOMETRIUM TUMOR; FEMALE; LABORATORY DIAGNOSIS; METHODOLOGY; PATHOLOGY; REVIEW; SENTINEL LYMPH NODE BIOPSY;

ENDOMETRIAL NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 34447321342     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2007.03.016     Document Type: Article

References (39)

1. Boyle P., and Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann. Oncol. 16 (2005) 481-488
2. Hill C., and Doyon F. The frequency of cancer in France: all ages and under age 15, mortality in 2003 and trends since 1968. Bull. Cancer 94 (2007) 7-13
3. Lurain J.R., Rice B.L., Rademaker A.W., Poggensee L.E., Schink J.C., and Miller D.S. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet. Gynecol. 78 (1991) 63-69
4. International Federation of Gynecology and Obstertrics. Corpus cancer staging. Int. J. Gynecol. Obstet. 28 (1989) 189-190
5. American Joint Comitte on Cancer. Manual for staging cancer 4th ed. (1992), Lippincott, Philadelphia 155-157
6. Bremond A., Bataillard A., Thomas L., Achard J.L., Fervers B., Fondrinier E., et al. Standards, Options and Recommendations for the surgical management of carcinoma of the endometrium. Bull. Cancer 88 (2001) 181-198
7. Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., and Heller P.B. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60 Suppl 8 (1987) 2035-2041
8. Morrow C.P., Bundy B.N., Kurman R.J., Creasman W.T., Heller P., Homesley H.D., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol. Oncol. 40 (1991) 55-65
9. Podratz K.C., Mariani A., and Webb M.J. Staging and therapeutic value of lymphadenectomy in endometrial cancer. Gynecol. Oncol. 70 (1998) 163-164
10. Querleu D., Leblanc E., Martel P., Ferron G., and Narducci F. Lymph node dissection in the surgical management of stage I endometrial carcinomas. Gynecol. Obstet. Fertil. 31 (2003) 1004-1012
11. Homesley H.D., Kadar N., Barrett R.J., and Lentz S.S. Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Am. J. Obstet. Gynecol. 167 (1992) 1225-1230
12. Chua B., Olivotto I.A., Donald J.C., Hayashi A.H., Doris P.J., Turner L.J., et al. Outcomes of sentinel node biopsy for breast cancer in British Columbia, 1996 to 2001. Am. J. Surg. 185 (2003) 118-126
13. Veronesi U., Paganelli G., Viale G., Luini A., Zurrida S., Galimberti V., et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol. 7 (2006) 983-990
14. Veronesi U., Paganelli G., Viale G., Luini A., Zurrida S., Galimberti V., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N. Engl. J. Med. 349 (2003) 546-553
15. Burke T.W., Levenback C., Tornos C., Morris M., Wharton J.T., and Gershenson D.M. Intraabdominal lymphatic mapping to direct selective pelvic and para-aortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol. Oncol. 62 (1996) 169-173
16. Pelosi E., Arena V., Baudino B., Bello M., Gargiulo T., Giusti M., et al. Preliminary study of sentinel node identification with 99mTc colloid and blue dye in patients with endometrial cancer. Tumori 88 (2002) S9-S10
17. Holub Z., Jabor A., and Kliment L. Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. Eur. J. Gynaecol. Oncol. 23 (2002) 53-57
18. Maccauro M., Lucignani G., Aliberti G., Villano C., Castellani M.R., Solima E., et al. Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer. Eur. J. Nucl. Med. Mol. Imaging 32 (2005) 569-574
19. Echt M.L., Finan M.A., Hoffman M.S., Kline R.C., Roberts W.S., and Fiorica J.V. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South. Med. J. 92 (1999) 204-208
20. Pelosi E., Arena V., Baudino B., Bello M., Giusti M., Gargiulo T., et al. Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl. Med. Commun. 24 (2003) 971-975
21. Barranger E., Cortez A., Grahek D., Callard P., Uzan S., and Darai E. Laparoscopic sentinel node procedure using a combination of patent blue and radiocolloid in women with endometrial cancer. Ann. Surg. Oncol. 11 (2004) 344-349
22. Fersis N., Gruber I., Relakis K., Friedrich M., Becker S., Wallwiener D., et al. Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer. Eur. J. Gynaecol. Oncol. 25 (2004) 339-342
23. Gien L.T., Kwon J.S., and Carey M.S. Sentinel node mapping with isosulfan blue dye in endometrial cancer. J. Obstet. Gynaecol. Can. 27 (2005) 1107-1112
24. Niikura H., Okamura C., Utsunomiya H., Yoshinaga K., Akahira J., Ito K., et al. Sentinel lymph node detection in patients with endometrial cancer. Gynecol. Oncol. 92 (2004) 669-674
25. Raspagliesi F., Ditto A., Kusamura S., Fontanelli R., Vecchione F., Maccauro M., et al. Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study. Am. J. Obstet. Gynecol. 191 (2004) 435-439
26. Barranger E., and Darai E. Relevance of the sentinel node procedure in endometrial cancer. Gynecol. Oncol. 94 (2004) 861-862
27. Barranger E., Uzan S., and Darai E. Lymphatic mapping for endometrial cancer: is hysteroscopic injection a safe technique for sentinel lymph node biopsy?. Am. J. Obstet. Gynecol. 193 (2005) 1880-1881
28. Gu M., Shi W., Huang J., Barakat R.R., Thaler H.T., and Saigo P.E. Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma. Cancer 90 (2000) 143-147
29. Frumovitz M., Bodurka D.C., Broaddus R.R., Coleman R.L., Sood A.K., Gershenson D.M., et al. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol. Oncol. 104 (2007) 100-103
30. Bats A.S., Clement D., Larousserie F., Lefrere-Belda M.A., Faraggi M., Froissart M., et al. Is sentinel node biopsy feasible in endometrial cancer? Results in 26 patients. J. Gynecol. Obstet. Biol. Reprod. (Paris) 34 (2005) 768-774
31. Mariani A., Webb M.J., Keeney G.L., and Podratz K.C. Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Gynecol. Oncol. 81 (2001) 100-104
32. Lécuru F., Neji K., Robin F., Darles C., Bièvre P., and Taurelle R. Drainage lymphatique de l'utérus. Résultats préliminaires d'une étude expérimentale. J. Gynecol. Obstet. Biol. Reprod. (Paris) 26 (1997) 418-423
33. Henriksen E. The lymphatic dissemination in endometrial carcinoma. A study of 188 necropsies. Am. J. Obstet. Gynecol. 123 (1975) 570-576
34. Holub Z., Jabor A., Lukac J., and Kliment L. Laparoscopic detection of sentinel lymph nodes using blue dye in women with cervical and endometrial cancer. Med. Sci. Monit. 10 (2004) CR587-CR591
35. Lanvin D., Elhage A., Henry B., Leblanc E., Querleu D., and Delobelle-Deroide A. Accuracy and safety of laparoscopic lymphadenectomy: an experimental prospective randomized study. Gynecol. Oncol. 67 (1997) 83-87
36. Childers J.M., Brzechffa P.R., Hatch K.D., and Surwit E.A. Laparoscopically assisted surgical staging (LASS) of endometrial cancer. Gynecol. Oncol. 51 (1993) 33-38
37. Querleu D., Leblanc E., Cartron G., Narducci F., Ferron G., and Martel P. Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patients. Am. J. Obstet. Gynecol. 195 (2006) 1287-1292
38. Abu-Rustum N.R., Alektiar K., Iasonos A., Lev G., Sonoda Y., Aghajanian C., et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol. Oncol. 103 (2006) 714-718
39. Yabushita H., Shimazu M., Yamada H., Sawaguchi K., Noguchi M., Nakanishi M., et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol. Oncol. 80 (2001) 139-144